secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0000950170-24-076330
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TRACON gets Nasdaq delisting notice; CBDO resigns
-------------------------------------------------

- Nasdaq Hearings Panel determined to delist TCON common stock effective June 13, 2024 for noncompliance with continued listing requirements.
- Trading continues on Nasdaq as of filing date; company expects to move to OTCQB Venture Market under symbol TCON.
- David Lazar voluntarily resigned as Chief Business Development Officer effective June 19, 2024; no disagreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/0000950170-24-076330-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024076330/tcon-20240619.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-076330

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer